Origin of the epidermal calcium gradient:: Regulation by barrier status and role of active vs passive mechanisms

被引:105
作者
Elias, PM
Ahn, SK
Brown, BE
Crumrine, D
Feingold, KR
机构
[1] Vet Adm Med Ctr, Dermatol Serv, San Francisco, CA 94121 USA
[2] Vet Adm Med Ctr, Med Serv, San Francisco, CA 94121 USA
[3] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
[5] Yonsei Univ, Dept Dermatol, Wonju Coll Med, Wonju, South Korea
关键词
calcium; cold; differentiation; epidermis; transepidermal water loss; ultrastructure;
D O I
10.1046/j.1523-1747.2002.19622.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mammalian epidermis displays a characteristic calcium gradient, with low calcium levels in the lower, basal, and spinous epidermal layers, whereas calcium levels increase progressively towards the outer stratum granulosum, and declining again in the stratum corneum. As the calcium gradient disappears after acute permeability barrier disruption, and returns after 6 h in parallel with barrier recovery, barrier function (through restriction of transcutaneous water movement) could regulate the formation of the epidermal calcium gradient. Two types of experiments confirmed the role of barrier status in regulating the calcium gradient: (i) either a vapor-permeable membrane (Gore-Tex(R)) or an emollient (Vaseline(R)), applied after acute barrier disruption, immediately restored barrier function, while accelerating the return of the calcium gradient, and (ii) in contrast, applications of lovastatin, a cholesterol synthesis inhibitor, which delayed barrier recovery and retarded the return of the calcium gradient. We next asked whether the calcium gradient is formed/maintained by passive and/or active mechanisms. Previous studies have demonstrated that cold exposure (4degreesC) blocks permeability barrier recovery after acute disruption. Here, we abrogated the barrier with tape-stripping, and then compared barrier recovery and restoration of the calcium gradient in hairless mice exposed to 4degreesC external temperatures, with and without occlusion with Gore-Tex(R). Although low levels of returned calcium throughout the epidermis, acutely disrupted, unoccluded, cold-exposed sites showed neither barrier recovery nor reappearance of the calcium gradient at 5 h. In contrast, acutely disrupted, cold-exposed sites, covered with Gore-Tex(R), likewise displayed little barrier recovery, but the calcium gradient largely returned by 3 h. These results show that (i) barrier status regulates formation of the calcium gradient, and (ii) passive processes alone can account for the formation/maintenance of the calcium gradient.
引用
收藏
页码:1269 / 1274
页数:6
相关论文
共 41 条
[1]  
Bale S J, 2000, J Cutan Med Surg, V4, P103
[2]   Changes in calcium responsiveness and handling during keratinocyte differentiation - Potential role of the calcium receptor [J].
Bikle, DD ;
Ratnam, A ;
Mauro, T ;
Harris, J ;
Pillai, S .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :1085-1093
[3]   Exposure to a dry environment enhances epidermal permeability barrier function [J].
Denda, M ;
Sato, J ;
Masuda, Y ;
Tsuchiya, T ;
Koyama, J ;
Kuramoto, M ;
Elias, PM ;
Feingold, KR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (05) :858-863
[4]  
DETMAR M, 1990, ACTA DERM-VENEREOL, V70, P295
[5]  
Elias P M, 1998, J Investig Dermatol Symp Proc, V3, P87
[6]  
Elias P M, 1999, Am J Contact Dermat, V10, P119, DOI 10.1016/S1046-199X(99)90054-4
[7]   Formation of the epidermal calcium gradient coincides with key milestones of barrier ontogenesis in the rodent [J].
Elias, PM ;
Nau, P ;
Hanley, K ;
Cullander, C ;
Crumrine, D ;
Bench, G ;
Sideras-Haddad, E ;
Mauro, T ;
Williams, ML ;
Feingold, KR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) :399-404
[8]  
ELIAS PM, 1991, ADV LIPID RES, V24, P1
[9]  
ELIAS PM, 2002, J INVEST DERMATOL, V119
[10]   CHOLESTEROL-SYNTHESIS IS REQUIRED FOR CUTANEOUS BARRIER FUNCTION IN MICE [J].
FEINGOLD, KR ;
MAN, MQ ;
MENON, GK ;
CHO, SS ;
BROWN, BE ;
ELIAS, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) :1738-1745